查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1487655

阿茲海默症藥物市場（藥物類別：膽鹼能、美金剛、聯合藥物等）- 2024-2034 年全球產業分析、規模、佔有率、成長、趨勢和預測

Alzheimer's Drugs Market (Drug Class: Cholinergic, Memantine, Combined Drugs, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

阿茲海默症藥物市場 - 報告範圍

TMR 關於全球阿茲海默症藥物市場的報告研究了過去以及當前的成長趨勢和機會，以獲得2024 年至2034 年預測期內市場指標的寶貴見解。市場的收入2018-2034年期間，考慮2024年為基準年，2034年為預測年。報告中也提供了2024年至2034年全球阿茲海默症藥物市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解阿茲海默症藥物市場。

市場概況
2023年市場價值 40 億美元
2034 年市場價值 116 億美元
複合年成長率 10%

該報告深入研究了全球阿茲海默症藥物市場的競爭格局。全球阿茲海默症藥物市場的主要參與者已經確定，並且每位參與者的不同屬性都已被描述。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球阿茲海默症藥物市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034年市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 關鍵技術/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依藥物類別

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依藥品類別，2020-2034
    • 膽鹼能
    • 美金剛
    • 聯合藥物
    • 其他
  • 市場吸引力分析：依藥品類別

第 7 章：全球市場分析與預測：按配銷通路

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按配銷通路，2020-2034
    • 醫院藥房
    • 零售藥局
    • 網上銷售
  • 市場吸引力分析：按應用

第 8 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2034
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 9 章：北美市場分析與預測

第 10 章：歐洲市場分析與預測

第 11 章：亞太市場分析與預測

第 12 章：拉丁美洲市場分析與預測

第 13 章：中東和非洲市場分析與預測

第14章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2023）
  • 公司簡介
    • Allergan plc
    • Novartis AG
    • Eisai Co. Ltd.
    • Johnson & Johnson
    • Daiichi Sankyo Company Limited
    • Ono Pharmaceutical Co. Ltd.
    • H Lundbeck A/S
    • Merz Holding GmbH & Co. KG
Product Code: TMRGL1245

Alzheimer's Drugs Market - Scope of Report

TMR's report on the global Alzheimer's drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global Alzheimer's drugs market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Alzheimer's drugs market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Alzheimer's drugs market.

Market Snapshot
Market Value in 2023US$ 4 Bn
Market Value in 2034US$ 11.6 Bn
CAGR10%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Alzheimer's drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Alzheimer's drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Alzheimer's drugs market.

The report delves into the competitive landscape of the global Alzheimer's drugs market. Key players operating in the global Alzheimer's drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Alzheimer's drugs market profiled in this report.

Key Questions Answered in Global Alzheimer's drugs Market Report:

  • What is the sales/revenue generated by Alzheimer's drugs across all regions during the forecast period?
  • What are the opportunities in the global Alzheimer's drugs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Alzheimer's Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global Alzheimer's drugs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Alzheimer's drugs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Alzheimer's drugs market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Alzheimer's Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology, Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Alzheimer's Drugs Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology, /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Alzheimer's Drugs Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Class, 2020-2034
    • 6.3.1. Cholinergic
    • 6.3.2. Memantine
    • 6.3.3. Combined Drugs
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Drug Class

7. Global Alzheimer's Drugs Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Sales
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Alzheimer's Drugs Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2020-2034
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Alzheimer's Drugs Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Market Value Forecast, by Drug Class, 2020-2034
    • 9.3.1. Cholinergic
    • 9.3.2. Memantine
    • 9.3.3. Combined Drugs
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.4.1. Hospital Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Online Sales
  • 9.5. Market Value Forecast, by Country, 2020-2034
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Drug Class,
    • 9.6.2. By Distribution Channel
    • 9.6.3. By Country

10. Europe Alzheimer's Drugs Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Drug Class, 2020-2034
    • 10.3.1. Cholinergic
    • 10.3.2. Memantine
    • 10.3.3. Combined Drugs
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Sales
  • 10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Italy
    • 10.5.5. Spain
    • 10.5.6. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Class
    • 10.6.2. By Distribution Channel
    • 10.6.3. By Country/Sub-region

11. Asia Pacific Alzheimer's Drugs Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Drug Class, 2020-2034
    • 11.3.1. Cholinergic
    • 11.3.2. Memantine
    • 11.3.3. Combined Drugs
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Sales
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.5.1. China
    • 11.5.2. Japan
    • 11.5.3. India
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Class,
    • 11.6.2. By Distribution Channel
    • 11.6.3. By Country/Sub-region

12. Latin America Alzheimer's Drugs Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Drug Class, 2020-2034
    • 12.3.1. Cholinergic
    • 12.3.2. Memantine
    • 12.3.3. Combined Drugs
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Sales
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Class,
    • 12.6.2. By Distribution Channel
    • 12.6.3. By Country/Sub-region

13. Middle East & Africa Alzheimer's Drugs Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Drug Class, 2020-2034
    • 13.3.1. Cholinergic
    • 13.3.2. Memantine
    • 13.3.3. Combined Drugs
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Sales
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Class,
    • 13.6.2. By Distribution Channel
    • 13.6.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2023)
  • 14.3. Company Profiles
    • 14.3.1. Allergan plc
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Technology, Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Financial Overview
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Novartis AG
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Technology, Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Financial Overview
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Eisai Co. Ltd.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Technology, Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Financial Overview
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Johnson & Johnson
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Technology, Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Financial Overview
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Daiichi Sankyo Company Limited
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Technology, Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Financial Overview
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Ono Pharmaceutical Co. Ltd.
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Technology, Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Financial Overview
      • 14.3.6.5. Strategic Overview
    • 14.3.7. H Lundbeck A/S
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Technology, Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Financial Overview
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Merz Holding GmbH & Co. KG
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Technology, Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Financial Overview
      • 14.3.8.5. Strategic Overview

List of Tables

  • Table 01: Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 02: Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 03: Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 04: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 05: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 06: North America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 07: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 08: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 09: Europe Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 10: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 11: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 12: Asia Pacific Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 15: Latin America Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034
  • Table 18: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Alzheimer's Drugs Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Alzheimer's Drugs Market Revenue (US$ Mn), by Drug Class, 2023
  • Figure 03: Alzheimer's Drugs Market Value Share, by Drug Class, 2023
  • Figure 04: Alzheimer's Drugs Market Revenue (US$ Mn), by Distribution Channel, 2023
  • Figure 05: Alzheimer's Drugs Market Value Share, by Distribution Channel, 2023
  • Figure 06: Alzheimer's Drugs Market Value Share, by Region, 2023
  • Figure 07: Alzheimer's Drugs Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 08: Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 09: Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 10: Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 11: Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 12: Alzheimer's Drugs Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 13: Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 14: North America Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 15: North America Alzheimer's Drugs Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 16: North America Alzheimer's Drugs Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 17: North America Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 18: North America Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 19: North America Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 20: North America Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 21: Europe Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 22: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 23: Europe Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 24: Europe Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 25: Europe Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 26: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 27: Europe Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 28: Asia Pacific Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 29: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 30: Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 31: Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 32: Asia Pacific Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 33: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Asia Pacific Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 35: Latin America Alzheimer's Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 36: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 37: Latin America Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 38: Latin America Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 39: Latin America Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 40: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 41: Latin America Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 42: Middle East & Africa Alzheimer's Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 43: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 44: Middle East & Africa Alzheimer's Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 45: Middle East & Africa Alzheimer's Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034
  • Figure 46: Middle East & Africa Alzheimer's Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 47: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 48: Middle East & Africa Alzheimer's Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034